These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 33097097)

  • 1. NIATx-TI versus typical product training on e-health technology implementation: a clustered randomized controlled trial study protocol.
    White VM; Molfenter T; Gustafson DH; Horst J; Greller R; Gustafson DH; Kim JS; Preuss E; Cody O; Pisitthakarm P; Toy A
    Implement Sci; 2020 Oct; 15(1):94. PubMed ID: 33097097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adapting the stages of implementation completion to an evidence-based implementation strategy: The development of the NIATx stages of implementation completion.
    Ford JH; Zehner ME; Schaper H; Saldana L
    Implement Res Pract; 2023; 4():26334895231200379. PubMed ID: 37790170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of Smartphone Systems to Improve Quality of Life for People With Substance Use Disorder: Interim Report on a Randomized Controlled Trial.
    Gustafson D; Horst J; Boss D; Fleddermann K; Jacobson N; Roosa M; Ross JC; Gicquelais R; Vjorn O; Siegler T; Molfenter T
    JMIR Hum Factors; 2022 Jul; 9(3):e35125. PubMed ID: 35834315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using NIATx strategies to implement integrated services in routine care: a study protocol.
    Ford JH; Osborne EL; Assefa MT; McIlvaine AM; King AM; Campbell K; McGovern MP
    BMC Health Serv Res; 2018 Jun; 18(1):431. PubMed ID: 29884164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinician Perspectives on Barriers and Facilitators to Implementing e-Health Technology in Substance Use Disorder (SUD) Treatment Facilities.
    Fleddermann K; Molfenter T; Jacobson N; Horst J; Roosa MR; Boss D; Ross JC; Preuss E; Gustafson DH
    Subst Abuse; 2021; 15():11782218211053360. PubMed ID: 34720585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the implementation and sustainment facilitation (ISF) strategy as an effective adjunct to the Addiction Technology Transfer Center (ATTC) strategy: study protocol for a cluster randomized trial.
    Garner BR; Zehner M; Roosa MR; Martino S; Gotham HJ; Ball EL; Stilen P; Speck K; Vandersloot D; Rieckmann TR; Chaple M; Martin EG; Kaiser D; Ford JH
    Addict Sci Clin Pract; 2017 Nov; 12(1):32. PubMed ID: 29149909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating addiction treatment into primary care using mobile health technology: protocol for an implementation research study.
    Quanbeck AR; Gustafson DH; Marsch LA; McTavish F; Brown RT; Mares ML; Johnson R; Glass JE; Atwood AK; McDowell H
    Implement Sci; 2014 May; 9():65. PubMed ID: 24884976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The implementation and sustainment facilitation strategy improved implementation effectiveness and intervention effectiveness: Results from a cluster-randomized, type 2 hybrid trial.
    Garner BR; Gotham HJ; Chaple M; Martino S; Ford Ii JH; Roosa MR; Speck KJ; Vandersloot D; Bradshaw M; Ball EL; Toro AK; Griggs C; Tueller SJ
    Implement Res Pract; 2020; 1():. PubMed ID: 36189179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing integrated services in routine behavioral health care: primary outcomes from a cluster randomized controlled trial.
    Assefa MT; Ford JH; Osborne E; McIlvaine A; King A; Campbell K; Jo B; McGovern MP
    BMC Health Serv Res; 2019 Oct; 19(1):749. PubMed ID: 31651302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study protocol for a factorial-randomized controlled trial evaluating the implementation, costs, effectiveness, and sustainment of digital therapeutics for substance use disorder in primary care (DIGITS Trial).
    Glass JE; Dorsey CN; Beatty T; Bobb JF; Wong ES; Palazzo L; King D; Mogk J; Stefanik-Guizlo K; Idu A; Key D; Fortney JC; Thomas R; McWethy AG; Caldeiro RM; Bradley KA
    Implement Sci; 2023 Feb; 18(1):3. PubMed ID: 36726127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs.
    Frimpong JA; Parish CL; Feaster DJ; Gooden LK; Nelson MC; Matheson T; Siegel K; Haynes L; Linas BP; Assoumou SA; Tross S; Kyle T; Liguori TK; Toussaint O; Annane D; Metsch LR
    Trials; 2023 Sep; 24(1):609. PubMed ID: 37749635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A legal dispute resolution intervention for patients with substance use disorders: a study protocol for a randomized controlled trial.
    O'Neil MM; Johnson RA; Córdova D; Pryor J; Pinals DA
    BMC Public Health; 2023 Mar; 23(1):435. PubMed ID: 36879259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial.
    Molfenter T; Knudsen HK; Brown R; Jacobson N; Horst J; Van Etten M; Kim JS; Haram E; Collier E; Starr S; Toy A; Madden L
    Implement Sci; 2017 Nov; 12(1):135. PubMed ID: 29141653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery schools for improving behavioral and academic outcomes among students in recovery from substance use disorders: a systematic review.
    Hennessy EA; Tanner-Smith EE; Finch AJ; Sathe N; Kugley S
    Campbell Syst Rev; 2018; 14(1):1-86. PubMed ID: 37131375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Medication Access within Integrated Treatment for Individuals with Co-Occurring Disorders in Substance Use Treatment Agencies.
    Ford JH; Kaur A; Rao D; Gilson A; Bolt DM; Garneau HC; Saldana L; McGovern MP
    Implement Res Pract; 2021 Jan; 2():. PubMed ID: 34988462
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.